A Study to Evaluate the Benefit and Safety of GSK2982772 in Moderate to Severe Psoriasis Participants
Clinical trial NCT04316585 · COMPLETED
Trial details
- NCT number
- NCT04316585
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-28
- Primary completion
- 2021-09-13
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.